Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 781703, 12 pages
http://dx.doi.org/10.1155/2015/781703
Research Article

Nutritional Recovery with a Soybean Diet after Weaning Reduces Lipogenesis but Induces Inflammation in the Liver in Adult Rats Exposed to Protein Restriction during Intrauterine Life and Lactation

1Departamento de Alimentos e Nutrição, Faculdade de Nutrição, Universidade Federal de Mato Grosso (UFMT), 78060-900 Cuiabá, MT, Brazil
2Departamento de Química, Instituto de Ciências Exatas e da Terra, Universidade Federal de Mato Grosso (UFMT), 78060-900 Cuiabá, MT, Brazil
3Departamento de Clínica Médica Veterinária, Faculdade de Agronomia e Medicina Veterinária, Universidade Federal de Mato Grosso (UFMT), 78060-900 Cuiabá, MT, Brazil

Received 9 July 2014; Revised 23 October 2014; Accepted 18 November 2014

Academic Editor: Cristina E. Carnovale

Copyright © 2015 Sílvia Regina de Lima Reis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. A. Adams, P. Angulo, and K. D. Lindor, “Nonalcoholic fatty liver disease,” CMAJ, vol. 172, no. 7, pp. 899–905, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. J. D. Browning and J. D. Horton, “Molecular mediators of hepatic steatosis and liver injury,” Journal of Clinical Investigation, vol. 114, no. 2, pp. 147–152, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. B. A. Neuschwander-Tetri and S. H. Caldwell, “Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference,” Hepatology, vol. 37, no. 5, pp. 1202–1219, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Angulo, “Nonalcoholic fatty liver disease,” The New England Journal of Medicine, vol. 346, no. 16, pp. 1221–1231, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Qureshi and G. A. Abrams, “Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease,” World Journal of Gastroenterology, vol. 13, no. 26, pp. 3540–3553, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Marchesini, M. Brizi, A. M. Morselli-Labate et al., “Association of nonalcoholic fatty liver disease with insulin resistance,” The American Journal of Medicine, vol. 107, no. 5, pp. 450–455, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. K. L. Donnelly, C. I. Smith, S. J. Schwarzenberg, J. Jessurun, M. D. Boldt, and E. J. Parks, “Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease,” The Journal of Clinical Investigation, vol. 115, no. 5, pp. 1343–1351, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. G. F. Lewis, A. Carpentier, K. Adeli, and A. Giacca, “Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes,” Endocrine Reviews, vol. 23, no. 2, pp. 201–229, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. I. Shimomura, Y. Bashmakov, and J. D. Horton, “Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus,” The Journal of Biological Chemistry, vol. 274, no. 42, pp. 30028–30032, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Foretz, C. Pacot, I. Dugail et al., “ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose,” Molecular and Cellular Biology, vol. 19, no. 5, pp. 3760–3768, 1999. View at Google Scholar · View at Scopus
  11. U. Edvardsson, M. Bergström, M. Alexandersson, K. Bamberg, B. Ljung, and B. Dahllöf, “Rosiglitazone (BRL49653), a PPARγ-selective agonist, causes peroxisome proliferator-like liver effects in obese mice,” Journal of Lipid Research, vol. 40, no. 7, pp. 1177–1184, 1999. View at Google Scholar · View at Scopus
  12. Q.-G. Deng, H. She, J. H. Cheng et al., “Steatohepatitis induced by intragastric overfeeding in mice,” Hepatology, vol. 42, no. 4, pp. 905–914, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Mas, M. Danjoux, V. Garcia, S. Carpentier, B. Ségul, and T. Levade, “IL-6 deficiency attenuates murine diet-induced non-alcoholic steatohepatitis,” PLoS ONE, vol. 4, no. 11, Article ID e7929, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Crespo, A. Cayoen, P. Fernendez-Gil et al., “Gene expression of tumor necrosis factor α and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients,” Hepatology, vol. 34, no. 6, pp. 1158–1163, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. R. G. Baker, M. S. Hayden, and S. Ghosh, “NF-κB, inflammation, and metabolic disease,” Cell Metabolism, vol. 13, no. 1, pp. 11–22, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Asrih and F. R. Jornayvaz, “Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance,” Journal of Endocrinology, vol. 218, no. 3, pp. R25–R36, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. A. L. Menezes, M. P. Pereira, S. L. Buzelle et al., “A low-protein, high-carbohydrate diet increases de novo fatty acid synthesis from glycerol and glycerokinase content in the liver of growing rats,” Nutrition Research, vol. 33, no. 6, pp. 494–502, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Q. Latorraca, M. A. B. Reis, E. M. Carneiro et al., “Protein deficiency and nutritional recovery modulate insulin secretion and the early steps of insulin action in rats,” Journal of Nutrition, vol. 128, no. 10, pp. 1643–1649, 1998. View at Google Scholar · View at Scopus
  19. S. E. Ozanne, G. D. Smith, J. Tikerpae, and C. N. Hales, “Altered regulation of hepatic glucose output in the male offspring of protein-malnourished rat dams,” American Journal of Physiology: Endocrinology and Metabolism, vol. 270, no. 4, pp. E559–E564, 1996. View at Google Scholar · View at Scopus
  20. M. Q. Latorraca, L. F. Stoppiglia, M. H. G. Gomes-da-Silva et al., “Effect of the soybean flour diet on insulin secretion and action,” in Flour and Breads and Their Fortification in Health and Disease Prevention, V. Preedy, R. Watson, and V. Patel, Eds., pp. 495–506, Elsevier, London, UK, 1st edition, 2011. View at Google Scholar
  21. N. Torres, I. Torre-Villalvazo, and A. R. Tovar, “Regulation of lipid metabolism by soy protein and its implication in diseases mediated by lipid disorders,” The Journal of Nutritional Biochemistry, vol. 17, no. 6, pp. 365–373, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. O. Mezei, W. J. Banz, R. W. Steger, M. R. Peluso, T. A. Winters, and N. Shay, “Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells,” Journal of Nutrition, vol. 133, no. 5, pp. 1238–1243, 2003. View at Google Scholar · View at Scopus
  23. E. D. A. Oliveira, L. M. G. Cheim, R. V. Veloso et al., “Nutritional recovery with a soybean flour diet improves the insulin response to a glucose load without modifying glucose homeostasis,” Nutrition, vol. 24, no. 1, pp. 76–83, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. N. H. Feres, S. R. de Lima Reis, R. V. Veloso et al., “Soybean diet alters the insulin-signaling pathway in the liver of rats recovering from early-life malnutrition,” Nutrition, vol. 26, no. 4, pp. 441–448, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. A. A. Paiva, J. Z. Faiad, M. S. Taki et al., “A soyabean diet does not modify the activity of brown adipose tissue but alters the rate of lipolysis in the retroperitoneal white adipose tissue of male rats recovering from early-life malnutrition,” British Journal of Nutrition, vol. 108, no. 6, pp. 1042–1051, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. R. V. Veloso, M. Q. Latorraca, V. C. Arantes et al., “Soybean diet improves insulin secretion through activation of cAMP/PKA pathway in rats,” The Journal of Nutritional Biochemistry, vol. 19, no. 11, pp. 778–784, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. W. Q. Wolfson, C. Chon et al., “A rapid procedure for the estimation of total protein, true albumin, total globulin, alpha globulin, beta globulin and gamma globulin in 1.0 ml of serum,” The American Journal of Clinical Pathology, vol. 18, no. 9, pp. 723–730, 1948. View at Google Scholar · View at Scopus
  28. A. M. Scott, I. Atwater, and E. Rojas, “A method for the simultaneous measurement of insulin release and B cell membrane potential in single mouse islets of Langerhans,” Diabetologia, vol. 21, no. 5, pp. 470–475, 1981. View at Google Scholar · View at Scopus
  29. S. Ochoa, “Malic enzyme,” Methods Enzymology, vol. 1, pp. 739–753, 1951. View at Google Scholar
  30. R. Y. Hsu and H. Lardy, “Malic enzyme,” Methods Enzymology, vol. 1, pp. 230–235, 1969. View at Google Scholar
  31. P. A. Srere, “The citrate cleavage enzyme. I. Distribution and purification,” The Journal of Biological Chemistry, vol. 234, pp. 2544–2547, 1959. View at Google Scholar · View at Scopus
  32. J. Folch, M. Lees, and G. H. S. Stanley, “A simple method for the isolation and purification of total lipides from animal tissues,” The Journal of Biological Chemistry, vol. 226, no. 1, pp. 497–509, 1957. View at Google Scholar · View at Scopus
  33. R. H. Migliorini and C. Linder, “Oxytocin and lipogenesis by adipose tissue in vitro,” Biochimica et Biophysica Acta: Lipids and Lipid Metabolism, vol. 125, no. 2, pp. 392–394, 1966. View at Publisher · View at Google Scholar · View at Scopus
  34. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at Publisher · View at Google Scholar · View at Scopus
  35. U. K. Laemmli, “Cleavage of structural proteins during the assembly of the head of bacteriophage T4,” Nature, vol. 227, no. 5259, pp. 680–685, 1970. View at Publisher · View at Google Scholar · View at Scopus
  36. C. A. Siegrist-Kaiser, V. Pauli, C. E. Juge-Aubry et al., “Direct effects of leptin on brown and white adipose tissue,” Journal of Clinical Investigation, vol. 100, no. 11, pp. 2858–2864, 1997. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Milanski, K. L. A. Souza, S. R. L. Reis et al., “Soybean diet modulates acetyl-coenzyme A carboxylase expression in livers of rats recovering from early-life malnutrition,” Nutrition, vol. 25, no. 7-8, pp. 774–781, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. R. R. Sokal and F. J. Rohlf, “Assumptions of analysis of variance,” in The Principles and Practice of Statistics in Biological Research, R. R. Sokal and F. J. Rohlf, Eds., pp. 392–450, W. H. Freeman, New York, NY, USA, 1995. View at Google Scholar
  39. N. Baba, H. Radwan, and T. V. Itallie, “Effects of casein versus soyprotein diets on body composition and serum lipid levels in adult rats,” Nutrition Research, vol. 12, no. 2, pp. 279–288, 1992. View at Publisher · View at Google Scholar · View at Scopus
  40. L. Bu, K. D. R. Setchell, and E. D. Lephart, “Influences of dietary soy isoflavones on metabolism but not nociception and stress hormone responses in ovariectomized female rats,” Reproductive Biology and Endocrinology, vol. 3, article 58, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Zhan and S. C. Ho, “Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile,” The American Journal of Clinical Nutrition, vol. 81, no. 2, pp. 397–408, 2005. View at Google Scholar · View at Scopus
  42. C. Ascencio, N. Torres, F. Isoard-Acosta, F. J. Gómez-Pérez, R. Hernández-Pando, and A. R. Tovar, “Soy protein affects serum insulin and hepatic SREBP-1 mRNA and reduces fatty liver in rats,” Journal of Nutrition, vol. 134, no. 3, pp. 522–529, 2004. View at Google Scholar · View at Scopus
  43. A. R. Tovar, C. Ascencio, and N. Torres, “Soy protein, casein, and zein regulate histidase gene expression by modulating serum glucagon,” American Journal of Physiology—Endocrinology and Metabolism, vol. 283, no. 5, pp. E1016–E1022, 2002. View at Google Scholar · View at Scopus
  44. B. Vozarova, N. Stefan, R. S. Lindsay et al., “High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes,” Diabetes, vol. 51, no. 6, pp. 1889–1895, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. L. P. Moura, G. A. Figueredo, N. O. Bertolini et al., “Dietary restriction, caloric value and the accumulation of hepatic fat,” Lipids in Health and Disease, vol. 11, article 2, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. K. Tobe, R. Suzuki, M. Aoyama et al., “Increased expression of the sterol regulatory element-binding protein-1 gene in insulin receptor substrate-2−/− mouse liver,” The Journal of Biological Chemistry, vol. 276, no. 42, pp. 38337–38340, 2001. View at Publisher · View at Google Scholar · View at Scopus
  47. E. S. Shin, H. H. Lee, S. Y. Cho, H. W. Park, S. J. Lee, and T. R. Lee, “Genistein downregulates SREBP-1 regulated gene expression by inhibiting site-1 protease expression in HepG2 cells,” Journal of Nutrition, vol. 137, no. 5, pp. 1127–1131, 2007. View at Google Scholar
  48. A. H. Hasty, H. Shimano, J.-I. Osuga et al., “Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low density lipoprotein receptor,” The Journal of Biological Chemistry, vol. 276, no. 40, pp. 37402–37408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  49. A. IJpenberg, E. Jeannin, W. Wahli, and B. Desvergne, “Polarity and specific sequence requirements of peroxisome proliferator-activated receptor (PPAR)/retinoid X receptor heterodimer binding to DNA. A functional analysis of the malic enzyme gene PPAR response element,” The Journal of Biological Chemistry, vol. 272, no. 32, pp. 20108–20117, 1997. View at Google Scholar
  50. K. Matsusue, M. Haluzik, G. Lambert et al., “Liver-specific disruption of PPARγ in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes,” The Journal of Clinical Investigation, vol. 111, no. 5, pp. 737–747, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. O. Gavrilova, M. Haluzik, K. Matsusue et al., “Liver peroxisome proliferator-activated receptor γ contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass,” The Journal of Biological Chemistry, vol. 278, no. 36, pp. 34268–34276, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. R. L. Drake, “Effects of various insulin dosages on hepatic lipogenesis,” Anatomical Record, vol. 220, no. 3, pp. 300–304, 1988. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Boll, L. W. D. Weber, and A. Stampfl, “Nutritional regulation of the activities of lipogenic enzymes of rat liver and brown adipose tissue,” Zeitschrift für Naturforschung C, vol. 51, no. 11-12, pp. 859–869, 1996. View at Google Scholar · View at Scopus
  54. L. A. Adams and P. Angulo, “Role of liver biopsy and serum markers of liver fibrosis in non-alcoholic fatty liver disease,” Clinics in Liver Disease, vol. 11, no. 1, pp. 25–35, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. R. M. McClain, E. Wolz, A. Davidovich, F. Pfannkuch, J. A. Edwards, and J. Bausch, “Acute, subchronic and chronic safety studies with genistein in rats,” Food and Chemical Toxicology, vol. 44, no. 1, pp. 56–80, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Kim, H.-J. Shin, S. Y. Kim et al., “Genistein enhances expression of genes involved in fatty acid catabolism through activation of PPARα,” Molecular and Cellular Endocrinology, vol. 220, no. 1-2, pp. 51–58, 2004. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Mandard, M. Müller, and S. Kersten, “Peroxisome proliferator-activated receptor α target genes,” Cellular and Molecular Life Sciences, vol. 61, no. 4, pp. 393–416, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. E. Ip, G. C. Farrell, G. Robertson, P. Hall, R. Kirsch, and I. Leclercq, “Central role of PPARα-dependent hepatic lipid turnover in dietary steatohepatitis in mice,” Hepatology, vol. 38, no. 1, pp. 123–132, 2003. View at Publisher · View at Google Scholar · View at Scopus
  59. K. Yamaguchi, L. Yang, S. McCall et al., “Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis,” Hepatology, vol. 45, no. 6, pp. 1366–1374, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. L. Abu-Elheiga, M. M. Matzuk, K. A. H. Abo-Hashema, and S. J. Wakil, “Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-coa carboxylase 2,” Science, vol. 291, no. 5513, pp. 2613–2616, 2001. View at Publisher · View at Google Scholar · View at Scopus
  61. T. Luedde and R. F. Schwabe, “NF-κB in the liver-linking injury, fibrosis and hepatocellular carcinoma,” Nature Reviews Gastroenterology & Hepatology, vol. 8, no. 2, pp. 108–118, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. L. Li, Q. He, X. Huang et al., “NOX3-derived reactive oxygen species promote TNF-α-induced reductions in hepatocyte glycogen levels via a JNK pathway,” FEBS Letters, vol. 584, no. 5, pp. 995–1000, 2010. View at Publisher · View at Google Scholar · View at Scopus